Innovative Drug Stocks Rebound Sharply; Boya Pharma Surges Over 10%, Hitting a Four-Year High

The concept of innovative drugs rebounded after hitting the bottom, with CQP's stock price surging over 10%, reaching a new high in more than four years. Northland, Jiangsu Aidea Pharmaceutical, Biokin, RemeGen, and Junshi Biosciences were among the top gainers.